Treatment Considerations: Medication Assisted Treatment of Opioid Use Disorders with Buprenorphine

Distance Training Glossary | Print Version | Email This Page To A Friend

Training Details

Event Dates and Timeframe
Wednesday, June 16, 2021 @ 11am - 12 Noon AKT (3ET/2CT/1MT/12PT)
Wednesday, June 16, 2021 at 11:00 AM until noon
Location and Delivery Method
Delivery Method
Online / Web Delivered
Support Website
https://my.naadac.org/
Cost Range
FREE to $15.00
Upon completing the webinar, click on the “Online CE Quiz” link above in the grey box to complete the online evaluation survey and CE quiz, and get your CE certificate. This link will be made available after the webinar takes place. NAADAC members will be prompted to register for the CE quiz for free, while non-members will be prompted to pay a $15 processing fee to access the quiz.

Host And Instructor

Host
National Association for Alcoholism and Drug Abuse Counselors (NAADAC)
Instructor
Jamelia Hand, MHS, CADC, CODP
class/provider logo image

Credits

C.E. Credit for NAADAC - The Association for Addiction Professionals: 1.00
To earn a CE Certificate for viewing this webinar, you must view the webinar in its entirety, complete the online evaluation, and pass the CE quiz. [Click here for more details](https://www.naadac.org/naadac-ce-acceptance)

Training Overview Description

Description

This webinar is an abbreviated course in “Buprenorphine 101.” It is well known that the role of healthcare and counseling professionals in the treatment of patients is profound. The goal of this interactive session is to enhance your professional knowledge surrounding outpatient based opioid treatment with Buprenorphine. Some of the topics covered include preparing patients for MAT with Buprenorphine, engaging patients in treatment, and connecting patients to resources. As a result of this session, attendees will increase their understanding of patient treatment challenges, understand their role in evolving the patient experience using strength-based approaches, and identify the benefits of combining counseling and Buprenorphine for long-term treatment success.

Learning Objectives

  • Participants will be able to describe office-based medication assisted treatment with Buprenorphine.

  • Participants will be able to restructure their role in evolving the patient experience with strength-based approaches.

  • Participants will be able to identify several benefits of combining counseling and Buprenorphine for long-term treatment success.

Content Level

Beginner and Intermediate.

Beginning level courses introduce learners to a content area; include information about a condition, treatment method, or issue; and involve learning and comprehending content.
Intermediate level courses provide information that builds on knowledge practitioners with some experience already have. These courses focus on skill-building or adding knowledge, possibly following a brief overview of basic information, and involve using information in concrete situations and understanding the underlying structure of the material.

Who Should Attend:

Addiction professionals, employee assistance professionals, social workers, mental health counselors, professional counselors, psychologists, and other helping professionals that are interested in learning about addiction-related matters.

Event-specific Details

This training could be applied to multiple areas of the Alaska Qualified Addictions Professional (QAP) certification. Contact the Alaska Commission for Behavioral Health Certification (Ask for Dabney Van Liere, Executive Director) at 907-332-4333 or email acbhc@akcertification.org for specific information.